Induction of TGF-β1, not regulatory T cells, impairs antiviral immunity in the lung following bone marrow transplant

Journal of Immunology

Volumn 184, Issue 9, 2010, Pages 5130-5140

  Coomes, Stephanie M ^a   Wilke, Carol A ^b   Moore, Thomas A ^b   Moore, Bethany B ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN; PROSTAGLANDIN E2; TRANSFORMING GROWTH FACTOR BETA1; GROWTH INHIBITOR; INTERLEUKIN 17; PROTEIN SERINE THREONINE KINASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA TYPE II RECEPTOR; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; HERPES VIRUS; HERPES VIRUS INFECTION; HOST RESISTANCE; LUNG; LUNG INFECTION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TH1 CELL; TH17 CELL; VIRUS IMMUNITY; VIRUS LOAD; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; C3H MOUSE; C57BL MOUSE; CELL DIFFERENTIATION; CELL PROLIFERATION; COMPARATIVE STUDY; GENETICS; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; METHODOLOGY; PATHOLOGY; RHADINOVIRUS; TRANSGENIC MOUSE; VIROLOGY; VIRUS INFECTION; VIRUS PNEUMONIA;

ANIMALS; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CELL PROLIFERATION; GROWTH INHIBITORS; HERPESVIRIDAE INFECTIONS; INTERLEUKIN-17; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, TRANSGENIC; PNEUMONIA, VIRAL; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RHADINOVIRUS; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TRANSFORMING GROWTH FACTOR BETA1; TRANSPLANTATION CONDITIONING; TUMOR VIRUS INFECTIONS;

EID: 77954477952     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901871     Document Type: Article

References (54)

1. Horowitz, M. M., F. R. Loberiza, C. N. Bredeson, J. D. Rizzo, and M. L. Nugent. 2001. Transplant registries: guiding clinical decisions and improving outcomes. Oncology (Williston Park) 15: 649-659; discussion 663-644, 666.
2. Copelan, E. A. 2006. Hematopoietic stem-cell transplantation. N. Engl. J. Med. 354: 1813-1826.
3. Soubani, A. O., K. B. Miller, and P. M. Hassoun. 1996. Pulmonary complications of bone marrow transplantation. Chest 109: 1066-1077. (Pubitemid 26113654)
4. Wald, A., W. Leisenring, J. A. van Burik, and R. A. Bowden. 1997. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J. Infect. Dis. 175: 1459-1466.
5. Lossos, I. S., R. Breuer, R. Or, N. Strauss, H. Elishoov, E. Naparstek, M. Aker, A. Nagler, A. E. Moses, M. Shapiro, et al. 1995. Bacterial pneumonia in recipients of bone marrow transplantation: a five-year prospective study. Transplantation 60: 672-678.
6. Konoplev, S., R. E. Champlin, S. Giralt, N. T. Ueno, I. Khouri, I. Raad, K. Rolston, K. Jacobson, J. Tarrand, M. Luna, et al. 2001. Cytomegalovirus pneumonia in adult autologous blood and marrow transplant recipients. Bone Marrow Transplant. 27: 877-881. (Pubitemid 32496423)
7. Kotloff, R. M., V. N. Ahya, and S. W. Crawford. 2004. Pulmonary complications of solid organ and hematopoietic stem cell transplantation. Am. J. Respir. Crit. Care Med. 170: 22-48.
8. Kontoyiannis, D. P., R. E. Lewis, and K. Marr. 2009. The burden of bacterial and viral infections in hematopoietic stem cell transplant. Biol. Blood Marrow Transplant. 15(Suppl. 1): 128-133.
9. Atkinson, K., I. Nivison-Smith, A. Dodds, A. Concannon, S. Milliken, and K. Downs. 1998. A comparison of the pattern of interstitial pneumonitis following allogeneic bone marrow transplantation before and after the introduction of prophylactic ganciclovir therapy in 1989. Bone Marrow Transplant. 21: 691-695. (Pubitemid 28159606)
10. Gohring, K., T. Feuchtinger, E. Mikeler, P. Lang, G. Jahn, R. Handgretinger, and K. Hamprecht. 2009. Dynamics of the emergence of a human cytomegalovirus UL97 mutant strain conferring ganciclovir resistance in a pediatric stem-cell transplant recipient. J. Mol. Diagn. 11: 364-368.
11. Burns, L. J. 2009. Late effects after autologous hematopoietic cell transplantation. Biol. Blood Marrow Transplant. 15(Suppl 1.): 21-24.
12. Jantunen, E., M. Itälä, T. Siitonen, E. Koivunen, S. Leppä, E. Juvonen, O. Kuittinen, T. Lehtinen, P. Koistinen, H. Nyman, et al. 2006. Late non-relapse mortality among adult autologous stem cell transplant recipients: a nation-wide analysis of 1,482 patients transplanted in 1990-2003. Eur. J. Haematol. 77: 114-119.
13. Ojielo, C. I., K. Cooke, P. Mancuso, T. J. Standiford, K. M. Olkiewicz, S. Clouthier, L. Corrion, M. N. Ballinger, G. B. Toews, R. Paine, III, and B. B. Moore. 2003. Defective phagocytosis and clearance of Pseudomonas aeruginosa in the lung following bone marrow transplantation. J. Immunol. 171: 4416-4424.
14. Ljungman, P. 2002. Prevention and treatment of viral infections in stem cell transplant recipients. Br. J. Haematol. 118: 44-57.
15. Efstathiou, S., Y. M. Ho, S. Hall, C. J. Styles, S. D. Scott, and U. A. Gompels. 1990. Murine herpesvirus 68 is genetically related to the gammaherpesviruses Epstein-Barr virus and herpesvirus saimiri. J. Gen. Virol. 71: 1365-1372.
16. Stewart, J. P., E. J. Usherwood, A. Ross, H. Dyson, and T. Nash. 1998. Lung epithelial cells are a major site of murine gammaherpesvirus persistence. J. Exp. Med. 187: 1941-1951.
17. Flaño, E., S. M. Husain, J. T. Sample, D. L. Woodland, and M. A. Blackman. 2000. Latent murine gamma-herpesvirus infection is established in activated B cells, dendritic cells, and macrophages. J. Immunol. 165: 1074-1081. (Pubitemid 30484779)
18. Doherty, P. C., J. P. Christensen, G. T. Belz, P. G. Stevenson, and M. Y. Sangster. 2001. Dissecting the host response to a gamma-herpesvirus. Philos. Trans. R. Soc. Lond. B Biol. Sci. 356: 581-593.
19. Sparks-Thissen, R. L., D. C. Braaten, K. Hildner, T. L. Murphy, K. M. Murphy, and H. W. Virgin, IV. 2005. CD4 T cell control of acute and latent murine gammaherpesvirus infection requires IFNγ. Virology 338: 201-208.
20. Gorelik, L., and R. A. Flavell. 2000. Abrogation of TGFb signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12: 171-181. (Pubitemid 30398631)
21. Faust, S. M., G. Lu, B. L. Marini, W. Zou, D. Gordon, Y. Iwakura, Y. Laouar, and D. K. Bishop. 2009. Role of T cell TGFb signaling and IL-17 in allograft acceptance and fibrosis associated with chronic rejection. J. Immunol. 183: 7297-7306.
22. 2 overproduction in impaired pulmonary host response following bone marrow transplantation. J. Immunol. 177: 5499-5508.
23. Hubbard, L. L., M. N. Ballinger, C. A. Wilke, and B. B. Moore. 2008. Comparison of conditioning regimens for alveolar macrophage reconstitution and innate immune function post bone marrow transplant. Exp. Lung Res. 34: 263-275.
24. McMillan, T. R., B. B. Moore, J. B. Weinberg, K. M. Vannella, W. B. Fields, P. J. Christensen, L. F. van Dyk, and G. B. Toews. 2008. Exacerbation of established pulmonary fibrosis in a murine model by gammaherpesvirus. Am. J. Respir. Crit. Care Med. 177: 771-780.
25. Weck, K. E., A. J. Dal Canto, J. D. Gould, A. K. O'Guin, K. A. Roth, J. E. Saffitz, S. H. Speck, and H. W. Virgin. 1997. Murine gamma-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-γ responsiveness: a new model for virus-induced vascular disease. Nat. Med. 3: 1346-1353.
26. + T cells during a pulmonary Cryptococcus neoformans infection. J. Immunol. 155: 4790-4797.
27. Kruisbeek, A. M., E. Shevach, and A. M. Thornton. 2004. Proliferative assays for T cell function. In Current Protocols in Immunology. J. E. Coligan, B. E. Bierer, D. H. Margulies, E. M. Shevach, W. Strober, and R. Coico, eds. John Wiley & Sons, Inc., Hoboken, NJ. p. 3.12.1-3.12.20.
28. Lutz, M. B., N. Kukutsch, A. L. Ogilvie, S. Rössner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223: 77-92.
29. -/- mice: implications for fibroproliferation. Am. J. Physiol. Lung Cell. Mol. Physiol. 284: L1103-L1111.
30. Corti, M., A. R. Brody, and J. H. Harrison. 1996. Isolation and primary culture of murine alveolar type II cells. Am. J. Respir. Cell Mol. Biol. 14: 309-315.
31. Shapiro, A. C., D. Wu, and S. N. Meydani. 1993. Eicosanoids derived from arachidonic and eicosapentaenoic acids inhibit T cell proliferative response. Prostaglandins 45: 229-240.
32. Martin, M., J. Lefaix, and S. Delanian. 2000. TGF-b1 and radiation fibrosis: a master switch and a specific therapeutic target? Int. J. Radiat. Oncol. Biol. Phys. 47: 277-290.
33. + regulatory T cells. Int. J. Clin. Exp. Med. 1: 192-202.
34. + T cells through a COX-2-PGE2-dependent mechanism. Int. Immunol. 20: 235-245.
35. + T cells. J. Immunol. 175: 1483-1490.
36. + Th1/Th2 T cells. Eur. J. Immunol. 30: 2101-2111.
37. Veldhoen, M., R. J. Hocking, C. J. Atkins, R. M. Locksley, and B. Stockinger. 2006. TGFb in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179-189. (Pubitemid 43214587)
38. Ackermann, M. 2006. Pathogenesis of gammaherpesvirus infections. Vet. Microbiol. 113: 211-222.
39. Schuurhuis, D. H., N. Fu, F. Ossendorp, and C. J. Melief. 2006. Ins and outs of dendritic cells. Int. Arch. Allergy Immunol. 140: 53-72.
40. Avigan, D., Z. Wu, R. Joyce, A. Elias, P. Richardson, D. McDermott, J. Levine, L. Kennedy, N. Giallombardo, D. Hurley, et al. 2000. Immune reconstitution following high-dose chemotherapy with stem cell rescue in patients with advanced breast cancer. Bone Marrow Transplant. 26: 169-176.
41. Sparks-Thissen, R. L., D. C. Braaten, S. Kreher, S. H. Speck, and H. W. Virgin, IV. 2004. An optimized CD4 T-cell response can control productive and latent gammaherpesvirus infection. J. Virol. 78: 6827-6835.
42. Nataraj, C., D. W. Thomas, S. L. Tilley, M. T. Nguyen, R. Mannon, B. H. Koller, and T. M. Coffman. 2001. Receptors for prostaglandin E2 that regulate cellular immune responses in the mouse. J. Clin. Invest. 108: 1229-1235.
43. Anscher, M. S., F. M. Kong, and R. L. Jirtle. 1998. The relevance of transforming growth factor β1 in pulmonary injury after radiation therapy. Lung Cancer 19: 109-120. (Pubitemid 28161303)
44. Gamble, J. R., Y. Khew-Goodall, and M. A. Vadas. 1993. Transforming growth factor-β inhibits E-selectin expression on human endothelial cells. J. Immunol. 150: 4494-4503. (Pubitemid 23133726)
45. Gamble, J. R., and M. A. Vadas. 1991. Endothelial cell adhesiveness for human T lymphocytes is inhibited by transforming growth factor-β1. J. Immunol. 146: 1149-1154.
46. Chin, Y. H., J. P. Cai, and X. M. Xu. 1992. Transforming growth factor-β1 and IL-4 regulate the adhesiveness of Peyer's patch high endothelial venule cells for lymphocytes. J. Immunol. 148: 1106-1112.
47. Tudor, K. S., K. L. Hess, and J. M. Cook-Mills. 2001. Cytokines modulate endothelial cell intracellular signal transduction required for VCAM-1-dependent lymphocyte transendothelial migration. Cytokine 15: 196-211.
48. Suzuki, Y., T. Tanigaki, D. Heimer, W. Wang, W. G. Ross, G. A. Murphy, A. Sakai, H. H. Sussman, T. H. Vu, and T. A. Raffin. 1994. TGF-β1 causes increased endothelial ICAM-1 expression and lung injury. J. Appl. Physiol. 77: 1281-1287.
49. Letterio, J. J., and A. B. Roberts. 1998. Regulation of immune responses by TGF-β. Annu. Rev. Immunol. 16: 137-161.
50. Wan, Y. Y., and R. A. Flavell. 2007. Regulatory T cells, transforming growth factor-β, and immune suppression. Proc. Am. Thorac. Soc. 4: 271-276.
51. Le, N. T., and N. Chao. 2007. Regulating regulatory T cells. Bone Marrow Transplant. 39: 1-9.
52. + T cells can expand and comprise a major component of the Treg compartment after experimental HCT. Blood 113: 733-743.
53. Nguyen, V. H., S. Shashidhar, D. S. Chang, L. Ho, N. Kambham, M. Bachmann, J. M. Brown, and R. S. Negrin. 2008. The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation. Blood 111: 945-953.
54. Sheng, H., J. Shao, E. B. Hooton, M. Tsujii, R. N. DuBois, and R. D. Beauchamp. 1997. Cyclooxygenase-2 induction and transforming growth factor β growth inhibition in rat intestinal epithelial cells. Cell Growth Differ. 8: 463-470. (Pubitemid 27273083)